Theralase Technologies Inc. announced a non-brokered private placement of 4,167,778 units at a price of CAD 0.18 per unit for the gross proceeds of CAD 750,200.04 on April 24, 2024. Each unit consists of one common share of the company and one common share purchase warrant. Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of CAD 0.25 per share for a period of 5 years following the date of issuance. All securities issued under the Offering will be subject to a four month and one day hold period from the closing date under applicable Canadian securities laws, which expires on August 25, 2024. The Offering is subject to receipt of final acceptance from the TSX Venture Exchange.

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from 16 placees.